Signet Financial Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$489K Buy
4,066
+166
+4% +$19.2K 0.05% 214
2025
Q4
$411K Sell
3,900
-318
-8% -$29.9K 0.05% 220
2025
Q3
$354K Buy
4,218
+447
+12% +$36.8K 0.04% 232
2025
Q2
$298K Buy
3,771
+1,323
+54% +$105K 0.04% 244
2025
Q1
$220K Sell
2,448
-62
-2% -$5.79K 0.03% 269
2024
Q4
$250K Buy
2,510
+35
+1% +$3.61K 0.03% 243
2024
Q3
$281K Sell
2,475
-7,773
-76% -$923K 0.04% 235
2024
Q2
$1.27M Sell
10,248
-65
-0.6% -$8.37K 0.17% 136
2024
Q1
$1.36M Buy
10,313
+214
+2% +$26.4K 0.19% 137
2023
Q4
$1.1M Sell
10,099
-293
-3% -$30.4K 0.16% 143
2023
Q3
$1.07M Sell
10,392
-961
-8% -$104K 0.18% 138
2023
Q2
$1.31M Sell
11,353
-446
-4% -$50.6K 0.21% 135
2023
Q1
$1.26M Sell
11,799
-861
-7% -$93K 0.21% 133
2022
Q4
$1.4M Sell
12,660
-69
-0.5% -$7.05K 0.25% 122
2022
Q3
$1.1M Buy
12,729
+2,638
+26% +$235K 0.21% 122
2022
Q2
$920K Sell
10,091
-516
-5% -$45.7K 0.18% 133
2022
Q1
$870K Buy
10,607
+676
+7% +$53.3K 0.15% 141
2021
Q4
$761K Sell
9,931
-227
-2% -$18.1K 0.12% 145
2021
Q3
$763K Buy
10,158
+375
+4% +$28.5K 0.13% 139
2021
Q2
$761K Sell
9,783
-973
-9% -$72.4K 0.26% 67
2021
Q1
$791K Sell
10,756
-994
-8% -$73.3K 0.15% 137
2020
Q4
$917K Sell
11,750
-91
-0.8% -$6.96K 0.19% 114
2020
Q3
$911K Sell
11,841
-289
-2% -$22.6K 0.2% 113
2020
Q2
$936K Sell
12,130
-11,655
-49% -$877K 0.21% 104
2020
Q1
$1.75M Sell
23,785
-1,843
-7% -$145K 0.41% 78
2019
Q4
$2.22M Buy
25,628
+113
+0.4% +$9.28K 0.42% 77
2019
Q3
$2.03M Buy
25,515
+10,568
+71% +$847K 0.4% 81
2019
Q2
$1.16M Buy
14,947
+3
+0% +$230 0.23% 108
2019
Q1
$1.13M Sell
14,944
-140
-0.9% -$10.5K 0.22% 111
2018
Q4
$1.1M Sell
15,084
-2
-0% -$141 0.24% 114
2018
Q3
$1.02M Sell
15,086
-265
-2% -$16.9K 0.18% 119
2018
Q2
$889K Buy
15,351
+45
+0.3% +$2.54K 0.16% 127
2018
Q1
$796K Buy
15,306
+74
+0.5% +$4K 0.14% 131
2017
Q4
$818K Sell
15,232
-52
-0.3% -$2.88K 0.15% 127
2017
Q3
$934K Buy
15,284
+472
+3% +$28.6K 0.18% 113
2017
Q2
$906K Sell
14,812
-524
-3% -$31.9K 0.19% 114
2017
Q1
$930K Buy
15,336
+11,108
+263% +$674K 0.2% 112
2016
Q4
$237K Sell
4,228
-393
-9% -$23K 0.06% 158
2016
Q3
$275K Buy
4,621
+776
+20% +$45.4K 0.06% 141
2016
Q2
$211K Buy
+3,845
New +$205K 0.05% 159
2016
Q1
Sell
-7,322
Closed -$369K 196
2015
Q4
$369K Buy
+7,322
New +$369K 0.08% 133
2015
Q3
Sell
-5,158
Closed -$280K 199
2015
Q2
$280K Buy
+5,158
New +$289K 0.06% 145
2015
Q1
Sell
-61,956
Closed -$3.36M 191
2014
Q4
$3.36M Buy
+61,956
New +$3.45M 1.23% 39

Other funds holding MRK

Signet Financial Management's MRK Position: Q1 2026 in Review

Signet Financial Management increased its Merck (MRK) stake by 4.3% in Q1 2026, buying an estimated $19.2K and bringing the position to 4,066 shares worth $489K. The position accounts for 0.05% of the portfolio, ranked #214.

Signet Financial Management first reported a position in MRK in Q4 2014 and has held it in 43 quarters since. The position peaked at $3.36M in Q4 2014. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Signet Financial Management held 4,066 shares of Merck worth $489K as of Q1 2026.
  • Signet Financial Management bought 166 Merck shares in Q1 2026, an estimated $19.2K.
  • Merck made up 0.05% of Signet Financial Management's portfolio in Q1 2026, its #214 holding.
  • Signet Financial Management first reported a position in Merck in Q4 2014 and has held it in 43 quarters since.
  • Signet Financial Management's Merck position peaked at $3.36M in Q4 2014.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.